| Company/Division name | Insulet Corp. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 1500 |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 170 |
| Country(ies) from which reshored: | China |
| City reshored to: | Acton |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | Omnipod, tubeless insulin pump |
| What non-domestic negative factors made offshoring less attractive? | Rising wages |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Government Incentives, Skilled workforce availability/training |
| Government Incentive dollar amount: | 4.4 million |
